Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3896029 | 1.00 | MEN1 (0.31) | MEN1KMT2ATDP1 | |
| SCHEMBL7451751 | 0.96 | — | — | |
| SCHEMBL5075434 | 0.88 | — | — | |
| SCHEMBL23609570 | 0.83 | — | — | |
| SCHEMBL14181169 | 0.76 | — | — | |
| SCHEMBL11880883 | 0.74 | — | — | |
| SCHEMBL11879654 | 0.74 | — | — | |
| SCHEMBL11859505 | 0.72 | — | — | |
| SCHEMBL11879982 | 0.72 | — | — | |
| Aliflurane SCHEMBL6659452 | 0.69 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1046394-A2 | Novel compositions useful for delivering compounds into a cell | ImaRx Pharmaceutical Corp. (US) | 2000-10-25 | — | — | EP | claimed |
| EP-3154591-B1 | PHOSPHOLIPID COMPOSITION AND MICROBUBBLES AND EMULSIONS FORMED USING SAME | UNGER EVAN C (US) | 2023-10-11 | — | — | EP | disclosed |
| EP-1039834-B1 | OPTOACOUSTIC CONTRAST AGENTS AND METHODS FOR THEIR USE | IMARX PHARMACEUTICAL CORP (US) | 2005-09-28 | — | — | EP | disclosed |
| US-20050011859-A1 | Unsaturated oxygenated fluorocarbons for selective aniostropic etch applications | VERSUM MATERIALS US, LLC | 2005-01-20 | — | — | US | disclosed |
| EP-1498941-A2 | Unsaturated oxygenated fluorocarbons for selective anisotropic etch applications | AIR PRODUCTS AND CHEMICALS, INC. (US) | 2005-01-19 | — | — | EP | disclosed |
| EP-1001816-A4 | PERFLUORINATED-ETHER COMPOSITIONS AS DIAGNOSTIC CONTRAST AGENTS | IMARX PHARMACEUTICAL CORP (US) | 2002-07-17 | — | — | EP | disclosed |
| EP-1039834-A4 | OPTOACOUSTIC CONTRAST AGENTS AND METHODS FOR THEIR USE | IMARX PHARMACEUTICAL CORP (US) | 2001-12-05 | — | — | EP | disclosed |
| EP-1039834-A1 | OPTOACOUSTIC CONTRAST AGENTS AND METHODS FOR THEIR USE | IMARX PHARMACEUTICAL CORP. (US) | 2000-10-04 | — | — | EP | disclosed |
| US-6123923-A | ADMINISTERING A PATIENT A CONTRAST AGENT CONTAINING A STABILIZER, A PHOTOACTIVE AGENT, A GASEOUS PRECURSOR SUCH AS PERFLUORINATED COMPOUND OR GAS OR BOTH, AND SCANNING THE PATIENT USING ULTRASOUND IMAGING AND OPTICAL IMAGING | IMARX PHARMACEUTICAL CORP. (US) | 2000-09-26 | — | — | US | disclosed |
| EP-1001816-A1 | PERFLUORINATED-ETHER COMPOSITIONS AS DIAGNOSTIC CONTRAST AGENTS | IMARX PHARMACEUTICAL CORP. (US) | 2000-05-24 | — | — | EP | disclosed |
| WO-1999030620-A1 | OPTOACOUSTIC CONTRAST AGENTS AND METHODS FOR THEIR USE | IMARX PHARMACEUTICAL CORP. (US) | 1999-06-24 | — | — | WO | disclosed |
| WO-1998023298-A1 | PERFLUORINATED-ETHER COMPOSITIONS AS DIAGNOSTIC CONTRAST AGENTS | IMARX PHARMACEUTICAL CORP. (US) | 1998-06-04 | — | — | WO | disclosed |